Attached files
| file | filename |
|---|---|
| EX-10.1 - Inotiv, Inc. | v206887_ex10-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 23, 2010
|
BIOANALYTICAL
SYSTEMS, INC.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Indiana
|
0-23357
|
35-1345024
|
||
|
(State or other
jurisdiction of
incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification
No.)
|
|
2701
KENT AVENUE
WEST
LAFAYETTE, INDIANA
|
47906-1382
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (765) 463-4527
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act(17CFR240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c))
Item
1.01 Entry into a Material Definitive Agreement
On December 23, 2010, Bioanalytical
Systems, Inc. (the "Company") executed an Amendment (“Amendment”) to its line of
credit agreement with Entrepreneur Growth Capital LLC. As part of the
Amendment, the maturity date for the line of credit was extended to January 31,
2013 and the line of credit will automatically renew each year thereafter until
either party gives the required notice of termination pursuant to the terms of
the agreement. The Amendment reduced the minimum tangible net worth
covenant requirement to $8.5 million and waived all non-compliances with this
covenant through the date of the Amendment.
The foregoing discussion of the
Amendment is entirely qualified by reference to the text of the Amendment, which
is attached as Exhibit 10.1 to this report, and incorporated herein by this
reference.
Item 9.01. Exhibits.
|
(d)
|
Exhibits
|
|
10.1
|
Amendment
to Loan Agreement between Bioanalytical Systems, Inc. and Entrepreneur
Growth Capital LLC, executed December 23,
2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Bioanalytical
Systems, Inc.
|
||
|
Date:
December 30, 2010
|
By:
|
/s/ Michael R. Cox
|
|
Michael
R. Cox
|
||
|
Vice
President, Finance and Administration, Chief Financial Officer and
Treasurer
|
||
Exhibit
Index
|
Exhibit No.
|
Description
|
|
|
10.1
|
Amendment
to Loan Agreement between Bioanalytical Systems, Inc. and Entrepreneur
Growth Capital LLC, executed December 23,
2010.
|